Sign in
VRAX Stock Price, Chart, Stats & News
Virax Biolabs Group Limited
Save
Virax Biolabs Group Limited (VRAX) does not currently pay a dividend.
608,398
Market cap
–
Current P/E
–
Forward P/E
VRAX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -8774.51% |
Operating margin | -196566.68% |
Pretax margin | -198510.88% |
Net margin | -189001.71% |
Effective tax rate | 4.62% |
ROA | -98.75% |
ROE | -102.54% |
D/E | 0.10x |
Interest coverage ratio | -92.32x |
VRAX valuation
P/E | – |
P/S | 231.64x |
P/B | 0.14x |
P/CF | -0.14x |
P/FCF | -0.11x |
P/OCF | -0.14x |
PEG | -0.01x |
EV multiple | -0.64x |
About
Virax Biolabs Group Limited is a biotechnology firm that specializes in the sale, distribution, and promotion of diagnostic testing kits, medical technology, and personal protective equipment (PPE). Its offerings are designed to aid in the prophylaxis, identification, diagnosis, and management of risks associated with viral illnesses within the immunology sector. Under its ViraxClear brand, the company provides a range of diagnostic tools, including rapid antibody IgG/IgM assays, antigen tests, polymerase chain reaction (PCR) rapid tests, and neutralizing antibody assessments.
Similar securities
Based on sector and market capitalization
Report issue